Amendment to Certain Agreements. The Company shall not enter into or consent to any amendment, supplement or other modification of the Operative Documents except as permitted under Article 9 hereof.
Amendment to Certain Agreements. Except as expressly provided for in the Transaction Documents, no Indenture Obligor shall, nor shall it permit any of its Obligor Subsidiaries to, amend, modify or supplement, or permit or consent to any amendment, modification or supplement of, the Exit Facility, the New Other Secured Notes And Claims and the Transaction Documents, except in each case to the extent such amendment, modification or supplement could not reasonably be expected to have a Material Adverse Effect.
Amendment to Certain Agreements. (a) No Obligor shall, without the consent of the Required Lenders, on or after the Closing Date, amend, modify or change in any manner any term or condition of any Other Bilateral Debt if such amendment, modification or change would have caused the Other Bilateral Debt Restructuring Conditions not to have been satisfied as of the Closing Date if such amendment, modification or change had occurred on or prior to such date;
(b) No Obligor shall, and Aracruz Celulose shall not cause or permit any other Aracruz Party to, without the consent of the Required Lenders, on or after the Closing Date, amend, modify or change in any manner any term or condition of any Permitted Refinancing Debt if such amendment, modification or change would have the effect of causing such Debt to fail to qualify as “Permitted Refinancing Debt” as defined herein;
(c) No Obligor shall, and Aracruz Celulose shall not cause or permit any other Aracruz Party to, without the consent of the Required Lenders, cancel or terminate any Aracruz Intercompany Notes or consent to or accept any cancellation or termination thereof, amend, modify or change in any manner any Aracruz Intercompany Notes or give any consent, waiver or approval thereunder, waive any default under or breach of any Aracruz Intercompany Notes, agree in any manner to any other amendment, modification or change of any term or condition of any Aracruz Intercompany Notes or take any other action in connection with any Aracruz Intercompany Notes, or permit any of its Subsidiaries to do any of the foregoing; and
(d) Neither Aracruz Celulose nor Xxxxxx shall, without the consent of the Majority Lenders, on or after the Closing Date, terminate, amend, modify or change in any manner any material term or condition of the Xxxxxx Lease.
Amendment to Certain Agreements. (a) Sections 4.1 and 7.2 of this Agreement shall, effective as of the date of this Agreement, supersede and replace Sections 20.16 and 20.17 of the Aventis Collaboration Agreement. The foregoing sentence shall not impair the rights of the Company or constitute a waiver by the Company of any breach or default by Aventis, Sanofi US or any of their Affiliates under Sections 20.16 and 20.17 of the Aventis Collaboration Agreement. Sanofi, the Investor, Sanofi US and the Company agree that Section 19.5 of the Aventis Collaboration Agreement is hereby amended and restated in its entirety to read: “Notwithstanding anything to the contrary herein, Regeneron will have the unilateral right to terminate this Agreement in its entirety, upon written notice to Aventis, if any of the Standstill Parties (as defined in the Amended and Restated Investor Agreement, dated as of January 11, 2014 (the “Investor Agreement”), by and among Sanofi, sanofi-aventis US LLC, Aventis, sanofi-aventis Amérique du Nord and Regeneron) shall have breached Section 4.1 of the Investor Agreement. For the avoidance of doubt, Regeneron shall not have the right to terminate this Agreement as a result of a de minimis breach of Section 4.1(a) of the Investor Agreement or an inadvertent breach of Section 4.1(g) of the Investor Agreement arising from informal discussions covering general corporate or other business matters the purpose of which is not intended to effectuate or lead to any of the actions referred to in paragraphs (a) through (e) of Section 4.1 of the Investor Agreement.” (b) Sanofi, the Investor, Sanofi US and the Company agree that Section 19.5 of the Sanofi License and Collaboration Agreement is hereby amended and restated in its entirety to read: “Regeneron shall have the unilateral right to terminate this Agreement in its entirety, effective immediately upon written notice to Sanofi, if Sanofi or any of its Affiliates shall have breached their obligations under any of Sections 4, 5 or 6 of the Investor Agreement (to the extent such sections of the Investor Agreement is then in effect). Furthermore, Regeneron shall have the unilateral right to terminate this Agreement in its entirety, effective immediately upon written notice to Sanofi, if Sanofi or any of its Affiliates shall have (a) breached their obligations under Section 20.16 of the Aventis Collaboration Agreement, to the extent that such Section 20.16 remains in effect after the Effective Date, or (b) breached its obligations u...
Amendment to Certain Agreements. Neither the Company nor any Subsidiary shall (a) enter into or consent to any amendment, supplement or other modification of this Agreement or the Security Documents except as permitted under Article IX hereof, and (b) amend, restate, supplement, modify, waive or otherwise change or consent or agree to any amendment, modification, waiver or other change to, any of the terms of the New Credit Agreement in any manner prohibited by the Intercreditor Agreement.
Amendment to Certain Agreements. 66 5.25 Waiver of Stay, Extension or Usury Laws........................................... 66
Amendment to Certain Agreements. Make, permit or consent to any amendment or other modification to the constitutional documents of any of the Loan Parties or any documents delivered in connection with any Permitted Acquisition, except to the extent that any such amendment (i) does not violate the terms and conditions of this Agreement or any of the other Loan Documents, (ii) does not materially adversely affect the interest of the Banks as creditor under this Agreement, the other Loan Documents or any other document or instrument in any respect and (iii) could not reasonably be expected to have a Material Adverse Effect.
Amendment to Certain Agreements. The Borrower shall not terminate, amend, supplement, waive, modify or change in any manner, or enter into any forbearance from exercising any rights with respect to, any term or condition of any Organizational Document or Contractual Obligation relating to any material Debt of the Borrower, if such termination, amendment, supplement, waiver, modification or change would adversely affect the Lenders, without in each case obtaining the prior written consent of the Majority Lenders to such termination, amendment, supplement, waiver, modification, change or forbearance.
Amendment to Certain Agreements. The Issuer shall not enter into or consent to any amendment, supplement or other modification of this Indenture or the Collateral Documents except as permitted under Article X hereof.
Amendment to Certain Agreements. 55 Section 5.12 Title to Collateral; Limitation on Liens.......................................... 55 Section 5.13 Books, Records, Access; Confidentiality........................................... 55 Section 5.14 Security Interests................................................................ 56 Section 5.15 Repurchase of Notes Upon a Change in Control...................................... 56 Section 5.16 Restrictions on Becoming an Investment Company.................................... 57 Section 5.17 Limitation on Indebtedness........................................................ 57 Section 5.18 Limitation on Distributions from Restricted Subsidiaries.......................... 59 Section 5.19 Limitation on Sales of Assets and Subsidiary Stock................................ 61 Section 5.20 Limitation on Affiliate Transactions.............................................. 62 Section 5.21 Limitation on the Sale or Issuance of Capital Stock of Restricted Subsidiaries.... 63 Section 5.22 Limitation on Guarantees by Restricted Subsidiaries............................... 63 Section 5.23 Limitation on Sale/Leaseback Transactions......................................... 64 Section 5.24 Excess Cash Flow Offer............................................................ 64 ARTICLE VI SUCCESSORS................................................................................. 65
